EUGENIE S KLEINERMAN to Brain Neoplasms
This is a "connection" page, showing publications EUGENIE S KLEINERMAN has written about Brain Neoplasms.
Connection Strength
0.064
-
Biologic response modifiers in pediatric cancer. Hematol Oncol Clin North Am. 2001 Aug; 15(4):723-40, ix.
Score: 0.015
-
Transfection of human topoisomerase II alpha into etoposide-resistant cells: transient increase in sensitivity followed by down-regulation of the endogenous gene. Biochem J. 1996 Oct 01; 319 ( Pt 1):307-13.
Score: 0.010
-
Effect of transfection of a Drosophila topoisomerase II gene into a human brain tumour cell line intrinsically resistant to etoposide. Br J Cancer. 1996 Jun; 73(11):1373-80.
Score: 0.010
-
Altered monocyte chemotactic and activating factor gene expression in human glioblastoma cell lines increased their susceptibility to cytotoxicity. J Leukoc Biol. 1996 Jun; 59(6):916-24.
Score: 0.010
-
Expression of topoisomerase II, bcl-2, and p53 in three human brain tumor cell lines and their possible relationship to intrinsic resistance to etoposide. Clin Cancer Res. 1995 Nov; 1(11):1391-7.
Score: 0.010
-
Pediatric patients with refractory central nervous system tumors: experiences of a clinical trial combining bevacizumab and temsirolimus. Anticancer Res. 2014 Apr; 34(4):1939-45.
Score: 0.009